Cargando…
Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response
Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasi...
Autores principales: | Kafetzopoulou, Liana E., Boocock, David J., Dhondalay, Gopal Krishna R., Powe, Desmond G., Ball, Graham R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology (RNCSB) Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962150/ https://www.ncbi.nlm.nih.gov/pubmed/24688711 http://dx.doi.org/10.5936/csbj.201303003 |
Ejemplares similares
-
Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas
por: Tong, Dong Ling, et al.
Publicado: (2014) -
DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer
por: Powe, Desmond G., et al.
Publicado: (2014) -
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
por: Gruet, Michael, et al.
Publicado: (2020) -
Alpha and beta adrenergic receptors modulate keratinocyte migration
por: Yang, Hsin-ya, et al.
Publicado: (2021) -
The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)